Alnylam Pharmaceuticals Inc ALNY:NASDAQ

RT Quote | NASDAQ | USD
Last | 05/26/22 EDT
125.60quote price arrow down-1.15 (-0.91%)
Volume
303,420
52 week range
117.58 - 212.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close125.60
  • 52 Week High212.00
  • 52 Week High Date10/14/21
  • 52 Week Low117.58
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap15.174B
  • Shares Out120.81M
  • 10 Day Average Volume0.77M
  • Dividend-
  • Dividend Yield-
  • Beta0.95
  • YTD % Change-25.93

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close125.60
  • 52 Week High212.00
  • 52 Week High Date10/14/21
  • 52 Week Low117.58
  • 52 Week Low Date05/12/22
  • Market Cap15.174B
  • Shares Out120.81M
  • 10 Day Average Volume0.77M
  • Dividend-
  • Dividend Yield-
  • Beta0.95
  • YTD % Change-25.93

RATIOS/PROFITABILITY

  • EPS (TTM)-7.48
  • P/E (TTM)-16.79
  • Fwd P/E (NTM)-18.92
  • EBITDA (TTM)-624.704M
  • ROE (TTM)-134.53%
  • Revenue (TTM)879.98M
  • Gross Margin (TTM)83.56%
  • Net Margin (TTM)-101.47%
  • Debt To Equity (MRQ)168.69%

EVENTS

  • Earnings Date08/01/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Alnylam Pharmaceuticals Inc

Profile

MORE
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It is developing therapeutics based on ribonucleic acid interference (RNAi). Its pipeline includes four products and multiple late and early-stage investigational RNAi therapeutics, that is focused in four strategic therapeutic areas (STArs): Genetic Medicines; Cardio-Metabolic Diseases; Hepatic Infectious Diseases; and CNS/Ocular Diseases. Its RNAi-based medicines include ONPATTRO (patisiran), GIVLAARI...
Michael Bonney
Executive Chairman of the Board
Yvonne Greenstreet
Chief Executive Officer, Director
Akshay Vaishnaw M.D., Ph.D.
President
Jeffrey Poulton
Chief Financial Officer, Executive Vice President
Indrani Franchini J.D.
Executive Vice President, Chief Legal Officer and Secretary
Address
675 W Kendall St
Cambridge, MA
02142-1168
United States

Top Peers

SYMBOLLASTCHG%CHG
NVZMY
Novozymes A/S
61.95UNCHUNCH
GMAB
Genmab A/S
29.81-0.19-0.63%
BHVN
Biohaven Pharmaceutical Holding Company Ltd
143.18-0.22-0.15%
INCY
Incyte Corp
76.02-0.49-0.64%
MRVI
Maravai LifeSciences Holdings Inc
34.50+0.29+0.85%